Substantia nigra Marinesco bodies are associated with decreased striatal expression of dopaminergic markers (Q44852327)

6 December 2017

title

Substantia nigra Marinesco bodies are associated with decreased striatal expression of dopaminergic markers (English)

1 reference

6 December 2017

1 reference

1 reference

1 reference

Thomas G Beach

1 reference

6 December 2017

Douglas G Walker

1 reference

6 December 2017

Lucia I Sue

1 reference

6 December 2017

Amanda Newell

series ordinal

1 reference

6 December 2017

Charles C Adler

series ordinal

1 reference

6 December 2017

Jeffrey N Joyce

series ordinal

1 reference

6 December 2017

publication date

1 April 2004

1 reference

Journal of Neuropathology & Experimental Neurology

6 December 2017

published in

1 reference

6 December 2017

1 reference

6 December 2017

1 reference

6 December 2017

page(s)

329-337

1 reference

The morphology of Marinesco bodies (paranucleolar corpuscles) in the melanin-pigmented nuclei of the brain-stem

6 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1093%2FJNEN%2F63.4.329

The effect of aging on pars compacta of the substantia nigra in rhesus monkey

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNEN%2F63.4.329

Intranuclear aggregation of nonexpanded ataxin-3 in marinesco bodies of the nonhuman primate substantia nigra.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNEN%2F63.4.329

Formation of neuronal intranuclear inclusions underlies the neurological dysfunction in mice transgenic for the HD mutation

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNEN%2F63.4.329

Aggregation of huntingtin in neuronal intranuclear inclusions and dystrophic neurites in brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNEN%2F63.4.329

Pathology of CAG repeat diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNEN%2F63.4.329

Fourteen and counting: unraveling trinucleotide repeat diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNEN%2F63.4.329

Preferential recruitment of ataxin-3 independent of expanded polyglutamine: an immunohistochemical study on Marinesco bodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNEN%2F63.4.329

Promyelocytic leukemia protein is redistributed during the formation of intranuclear inclusions independent of polyglutamine expansion: an immunohistochemical study on Marinesco bodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNEN%2F63.4.329

Neuropathological changes of the brain in myotonic dystrophy--some new observations

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNEN%2F63.4.329

Brain glyceraldehyde-3-phosphate dehydrogenase activity in human trinucleotide repeat disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNEN%2F63.4.329

Vacuole-creating protein in neurodegenerative diseases in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNEN%2F63.4.329

The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNEN%2F63.4.329

Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): report of the consortium on DLB international workshop

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNEN%2F63.4.329

Diagnostic criteria for Parkinson disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNEN%2F63.4.329

Dopamine D3 receptor is decreased and D2 receptor is elevated in the striatum of Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNEN%2F63.4.329

Loss of response to levodopa in Parkinson's disease and co-occurrence with dementia: role of D3 and not D2 receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNEN%2F63.4.329

Aging and Extrapyramidal Function

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNEN%2F63.4.329

Developmental and age-related changes of dopamine transporter, and dopamine D1 and D2 receptors in human basal ganglia

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNEN%2F63.4.329

Imaging of dopamine transporters with [123I]FP-CIT SPECT does not suggest a significant effect of age on the symptomatic threshold of disease in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNEN%2F63.4.329

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNEN%2F63.4.329

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNEN%2F63.4.329

[3H]CFT ([3H]WIN 35,428) accumulation in dopamine regions of monkey brain: comparison of a mature and an aged monkey

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNEN%2F63.4.329

Changes in somatodendritic but not terminal dopamine regulation in aged rhesus monkeys

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNEN%2F63.4.329

Ageing and Parkinson's disease: substantia nigra regional selectivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNEN%2F63.4.329

Unbiased morphometrical measurements show loss of pigmented nigral neurones with ageing.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNEN%2F63.4.329

Specific A10 dopaminergic nuclei in the midbrain degenerate in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNEN%2F63.4.329

Damage to dopamine systems differs between parkinson's disease and alzheimer's disease with parkinsonism

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNEN%2F63.4.329

Differential modification of dopamine transporter and tyrosine hydroxylase mRNAs in midbrain of subjects with Parkinson's, Alzheimer's with parkinsonism, and Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNEN%2F63.4.329

Senile dementia of Lewy body type. A clinically and neuropathologically distinct form of Lewy body dementia in the elderly

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNEN%2F63.4.329

Histone ubiquitination: a tagging tail unfolds?

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNEN%2F63.4.329

Ubiquitin in neurodegenerative diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNEN%2F63.4.329

Proteasomal function is impaired in substantia nigra in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNEN%2F63.4.329

Proteolytic stress: a unifying concept for the etiopathogenesis of Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNEN%2F63.4.329

Neurological disease: UPS stops delivering!

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNEN%2F63.4.329

Possible involvement of proteasome inhibition in aging: implications for oxidative stress.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNEN%2F63.4.329

Polyglutamine expansion as a pathological epitope in Huntington's disease and four dominant cerebellar ataxias

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNEN%2F63.4.329

Polyglutamine pathogenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNEN%2F63.4.329

Transcriptional dysregulation in Huntington's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNEN%2F63.4.329

Identification of genes that modify ataxin-1-induced neurodegeneration.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNEN%2F63.4.329

Recruitment of nonexpanded polyglutamine proteins to intranuclear aggregates in neuronal intranuclear hyaline inclusion disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNEN%2F63.4.329

Intracytoplasmic inclusion bodies of the substantia nigra in myotonic dystrophy. Immunohistochemical observations

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNEN%2F63.4.329

21 January 2018

The myotonic dystrophies

1 reference

https://api.crossref.org/works/10.1093%2FJNEN%2F63.4.329

21 January 2018

Identifiers

DOI

10.1093/JNEN/63.4.329

1 reference

6 December 2017

1 reference